The apolipoprotein(a) gene: linkage disequilibria at three loci differs in African Americans and Caucasians
- PMID: 18304554
- PMCID: PMC2784197
- DOI: 10.1016/j.atherosclerosis.2008.01.002
The apolipoprotein(a) gene: linkage disequilibria at three loci differs in African Americans and Caucasians
Abstract
Lipoprotein(a) (Lp(a)) is an independent, genetically regulated cardiovascular risk factor. Lp(a) plasma levels are largely determined by the apolipoprotein(a) (apo(a)) component, and differ across ethnicity. Although a number of polymorphisms in the apo(a) gene have been identified, apo(a) genetic regulation is not fully understood. To study the relation between apo(a) gene variants, we constructed haplotypes and assessed linkage equilibrium in African Americans and Caucasians for three widely studied apo(a) gene polymorphisms (apo(a) size, +93 C/T and pentanucleotide repeat region (PNR)). Apo(a) size allele frequency distributions were different across ethnicity (p<0.01). For African Americans, PNR frequencies were similar across apo(a) sizes, suggesting linkage equilibrium. For Caucasians, the PNR and the PNR-C/T haplotype frequencies differed for large and small apo(a), with the T and PNR 9 alleles associated with large apo(a) size (p<0.0002); also, the PNR 9 allele was more common on a T allele, while PNR 8 was more common on a C allele. On a C allele background, small PNR alleles were more common and the PNR 10 allele less common among African Americans than Caucasians (p<0.001). The ethnic difference in apo(a) size distribution remained controlling for C/T and PNR alleles (p=0.023). In conclusion, allele and haplotype frequencies and the nature of the linkage disequilibrium differed between African Americans and Caucasians at three apo(a) gene polymorphisms.
Figures

Similar articles
-
Apo[a] size and PNR explain African American-Caucasian differences in allele-specific apo[a] levels for small but not large apo[a].J Lipid Res. 2006 May;47(5):982-9. doi: 10.1194/jlr.M500359-JLR200. Epub 2006 Feb 22. J Lipid Res. 2006. PMID: 16495513
-
ApoE genotype affects allele-specific apo[a] levels for large apo[a] sizes in African Americans: the Harlem-Basset Study.J Lipid Res. 2007 Mar;48(3):693-8. doi: 10.1194/jlr.M600431-JLR200. Epub 2006 Dec 15. J Lipid Res. 2007. PMID: 17172560
-
High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African-Americans.J Clin Endocrinol Metab. 2008 Apr;93(4):1482-8. doi: 10.1210/jc.2007-2416. Epub 2008 Feb 5. J Clin Endocrinol Metab. 2008. PMID: 18252779 Free PMC article.
-
Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African-Americans.Atherosclerosis. 2014 Jul;235(1):223-9. doi: 10.1016/j.atherosclerosis.2014.04.035. Epub 2014 May 10. Atherosclerosis. 2014. PMID: 24859635 Free PMC article.
-
Lipoprotein(a), atherosclerosis, and apolipoprotein(a) gene polymorphism.Mol Genet Metab. 2000 Sep-Oct;71(1-2):87-92. doi: 10.1006/mgme.2000.3070. Mol Genet Metab. 2000. PMID: 11001801 Review.
Cited by
-
[Impact of lipid metabolism parameters on the development and progression of coronary artery disease : An update].Herz. 2016 Jun;41(4):273-80. doi: 10.1007/s00059-016-4430-8. Herz. 2016. PMID: 27215419 Review. German.
-
Lipoprotein(a): Emerging insights and therapeutics.Am J Prev Cardiol. 2024 Mar 29;18:100641. doi: 10.1016/j.ajpc.2024.100641. eCollection 2024 Jun. Am J Prev Cardiol. 2024. PMID: 38646022 Free PMC article.
-
Lipoprotein(a): a Case for Universal Screening in Youth.Curr Atheroscler Rep. 2023 Aug;25(8):487-493. doi: 10.1007/s11883-023-01120-3. Epub 2023 Jul 5. Curr Atheroscler Rep. 2023. PMID: 37405555 Review.
-
Lipoprotein(a)-Lowering Drugs: A Mini Review.J Clin Med Res. 2025 Apr;17(4):181-186. doi: 10.14740/jocmr6196. Epub 2025 Apr 11. J Clin Med Res. 2025. PMID: 40322720 Free PMC article. Review.
-
Investigation of a nonsense mutation located in the complex KIV-2 copy number variation region of apolipoprotein(a) in 10,910 individuals.Genome Med. 2020 Aug 21;12(1):74. doi: 10.1186/s13073-020-00771-0. Genome Med. 2020. PMID: 32825847 Free PMC article.
References
-
- Utermann G. The mysteries of lipoprotein(a). Science (Wash DC) 1998;246:904–10. - PubMed
-
- Stein JH, Rosenson RS. Lipoprotein Lp(a) excess and coronary heart disease. Arch. Intern. Med. 1997;157:1170–6. - PubMed
-
- Danesh J, Collins R, Peto R. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation. 2000;102:1082–5. - PubMed
-
- Rhoads GG, Dahlén G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA. 1986;256:2540–4. - PubMed
-
- Bostom AG, Gagnon DR, Cupples LA, Wilson PWF, Jenner JL, Ordovas JM, Schaefer EJ, Castelli WP. A prospective investigation of elevated lipoprotein(a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study. Circulation. 1994;90:1688–95. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous